ESLOF
Price
$310.51
Change
+$10.39 (+3.46%)
Updated
Sep 4 closing price
Capitalization
138.41B
ESLOY
Price
$152.22
Change
+$1.65 (+1.10%)
Updated
Sep 4 closing price
Capitalization
138.41B
41 days until earnings call
Interact to see
Advertisement

ESLOF vs ESLOY

Header iconESLOF vs ESLOY Comparison
Open Charts ESLOF vs ESLOYBanner chart's image
EssilorLuxottica
Price$310.51
Change+$10.39 (+3.46%)
Volume$1.01K
Capitalization138.41B
EssilorLuxottica
Price$152.22
Change+$1.65 (+1.10%)
Volume$19.76K
Capitalization138.41B
ESLOF vs ESLOY Comparison Chart in %
Loading...
ESLOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ESLOY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ESLOF vs. ESLOY commentary
Sep 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ESLOF is a StrongBuy and ESLOY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 05, 2025
Stock price -- (ESLOF: $310.51 vs. ESLOY: $152.22)
Brand notoriety: ESLOF and ESLOY are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ESLOF: 132% vs. ESLOY: 43%
Market capitalization -- ESLOF: $138.41B vs. ESLOY: $138.41B
ESLOF [@Pharmaceuticals: Other] is valued at $138.41B. ESLOY’s [@Pharmaceuticals: Other] market capitalization is $138.41B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $162.93B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.95B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ESLOF’s FA Score shows that 2 FA rating(s) are green whileESLOY’s FA Score has 3 green FA rating(s).

  • ESLOF’s FA Score: 2 green, 3 red.
  • ESLOY’s FA Score: 3 green, 2 red.
According to our system of comparison, ESLOY is a better buy in the long-term than ESLOF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ESLOF’s TA Score shows that 3 TA indicator(s) are bullish while ESLOY’s TA Score has 3 bullish TA indicator(s).

  • ESLOF’s TA Score: 3 bullish, 5 bearish.
  • ESLOY’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ESLOY is a better buy in the short-term than ESLOF.

Price Growth

ESLOF (@Pharmaceuticals: Other) experienced а +0.78% price change this week, while ESLOY (@Pharmaceuticals: Other) price change was -1.05% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.46%. For the same industry, the average monthly price growth was +6.49%, and the average quarterly price growth was +18.00%.

Reported Earning Dates

ESLOY is expected to report earnings on Oct 16, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-1.46% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ESLOF($138B) and ESLOY($138B) have the same market capitalization . ESLOF (51.83) and ESLOY (50.82) have similar P/E ratio . ESLOY (30.358) and ESLOF (29.245) have similar YTD gains . ESLOF (6.71B) and ESLOY (6.71B) have comparable annual earnings (EBITDA) . ESLOF (3.16B) and ESLOY (3.16B) have equal amount of cash in the bank . ESLOF (14B) and ESLOY (14B) have identical debt. ESLOF (27.2B) and ESLOY (27.2B) have equivalent revenues.
ESLOFESLOYESLOF / ESLOY
Capitalization138B138B100%
EBITDA6.71B6.71B100%
Gain YTD29.24530.35896%
P/E Ratio51.8350.82102%
Revenue27.2B27.2B100%
Total Cash3.16B3.16B100%
Total Debt14B14B100%
FUNDAMENTALS RATINGS
ESLOF vs ESLOY: Fundamental Ratings
ESLOF
ESLOY
OUTLOOK RATING
1..100
7265
VALUATION
overvalued / fair valued / undervalued
1..100
34
Fair valued
33
Fair valued
PROFIT vs RISK RATING
1..100
2115
SMR RATING
1..100
9696
PRICE GROWTH RATING
1..100
5250
P/E GROWTH RATING
1..100
2729
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ESLOY's Valuation (33) in the null industry is in the same range as ESLOF (34). This means that ESLOY’s stock grew similarly to ESLOF’s over the last 12 months.

ESLOY's Profit vs Risk Rating (15) in the null industry is in the same range as ESLOF (21). This means that ESLOY’s stock grew similarly to ESLOF’s over the last 12 months.

ESLOY's SMR Rating (96) in the null industry is in the same range as ESLOF (96). This means that ESLOY’s stock grew similarly to ESLOF’s over the last 12 months.

ESLOY's Price Growth Rating (50) in the null industry is in the same range as ESLOF (52). This means that ESLOY’s stock grew similarly to ESLOF’s over the last 12 months.

ESLOF's P/E Growth Rating (27) in the null industry is in the same range as ESLOY (29). This means that ESLOF’s stock grew similarly to ESLOY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ESLOFESLOY
RSI
ODDS (%)
Bearish Trend 1 day ago
55%
Bearish Trend 1 day ago
58%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
64%
Momentum
ODDS (%)
Bearish Trend 1 day ago
60%
Bearish Trend 1 day ago
43%
MACD
ODDS (%)
Bearish Trend 1 day ago
68%
Bearish Trend 1 day ago
49%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
66%
Bearish Trend 1 day ago
49%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
62%
Bullish Trend 1 day ago
53%
Advances
ODDS (%)
Bullish Trend 1 day ago
66%
Bullish Trend 1 day ago
60%
Declines
ODDS (%)
Bearish Trend 4 days ago
54%
Bearish Trend 4 days ago
50%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
60%
Bearish Trend 1 day ago
47%
Aroon
ODDS (%)
Bullish Trend 1 day ago
59%
Bullish Trend 1 day ago
48%
View a ticker or compare two or three
Interact to see
Advertisement
ESLOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ESLOY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
THRM35.85-0.03
-0.07%
Gentherm
MDLZ60.90-0.40
-0.65%
Mondelez International
ALLO1.11-0.01
-0.89%
Allogene Therapeutics
CISO0.88-0.02
-2.06%
CISO Global
GKOS90.14-4.33
-4.58%
Glaukos Corp

ESLOF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ESLOF has been loosely correlated with ESLOY. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if ESLOF jumps, then ESLOY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ESLOF
1D Price
Change %
ESLOF100%
+3.46%
ESLOY - ESLOF
58%
Loosely correlated
+1.10%
SAUHF - ESLOF
37%
Loosely correlated
-2.17%
SMMNY - ESLOF
33%
Loosely correlated
+1.07%
WILYY - ESLOF
21%
Poorly correlated
N/A
TRUMY - ESLOF
21%
Poorly correlated
-0.62%
More

ESLOY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ESLOY has been loosely correlated with ESLOF. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if ESLOY jumps, then ESLOF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ESLOY
1D Price
Change %
ESLOY100%
+1.10%
ESLOF - ESLOY
58%
Loosely correlated
+3.46%
SMMNY - ESLOY
41%
Loosely correlated
+1.07%
SAUHY - ESLOY
37%
Loosely correlated
+1.89%
CLPBY - ESLOY
33%
Poorly correlated
-0.92%
LZAGY - ESLOY
32%
Poorly correlated
+1.45%
More